Delivery Order SPE2DB22D2007-SPE2DB25FJ3YH
- Not listed
- The Defense Logistics Agency awarded a $1,255.80 delivery order to AmerisourceBergen Drug Corp for Albumin (Human) 5% IV Solution 250ml, with an ultimate completion date of August 19, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award is issued as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with...
- The Defense Logistics Agency awarded a $2,080.40 delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Albumin (Human) 25% Intravenous Solution, 50mL. This firm fixed-price contract represents a non-competitive delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and extending through December 2026. The product will be delivered to the company's facility in Conshohocken,...
- This federal contract award, valued at $1,040.20, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order contract for the supply of Albumin (Human) 25% IV Solution, a critical medical product, with a performance period extending through May 13, 2025. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- On August 1, 2025, the Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $12,496.56 to AmerisourceBergen Drug Corp for the supply of Albumin (Human) 25% Intravenous Solution in 100-milliliter units. This firm fixed-price delivery order, which is not set-aside, is scheduled for completion by August 22, 2025, with performance taking place at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Albumin (Human) 25% intravenous solution in 100 mL units. This competitively awarded, firm fixed-price delivery order carries a ceiling value of $2,080.20 and is scheduled for completion by August 26, 2025. The product will be delivered to the contractor's facility in Conshohocken, Pennsylvania. As a non-set-aside contract, this award was made through open competition and...
- This is a $1,668.10 firm fixed-price delivery order awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) for the supply of ALBUMIN (HUMAN) 25% IV SOLN 50ML. The contract has an ultimate completion date of June 20, 2025. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that serves as a critical supplier of medical and pharmaceutical products to federal agencies, including the DLA. This delivery order is part of a larger...
- The Defense Logistics Agency awarded a $2,080.40 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Albumin (Human) 25% intravenous solution in 50ml units. The contract, which is not set-aside, will be performed at the contractor's location in Conshohocken, Pennsylvania, with an ultimate completion date of August 13, 2025. This delivery order represents a continuation of AmerisourceBergen's substantial pharmaceutical supply relationship with DLA,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,005.20 firm-fixed-price delivery order is for the supply of Albumin (Human) 25% IV Solution, a pharmaceutical product used in medical care. The contract has an ultimate completion date of November 13, 2024 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Albumin (Human) 25% IV Solution, 100 milliliters, with a ceiling value of $4,992.48 and a completion date of July 28, 2025. The contract is a Firm Fixed Price, non-set-aside award. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,552.78, is for the delivery of 100 ml bottles of 25% Albumin (Human) Intravenous Solution. This is a firm fixed-price delivery order contract with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
- SPE2DB22D2007Indefinite Delivery Contract
- SPE2DB22D2007-SPE2DB25FJ3YHDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,040.20 to AmerisourceBergen Drug Corp for Albumin (Human) 25% IV Solution 50ML, with an ultimate completion date of September 5, 2025. This is a firm fixed price, competitively awarded delivery order with no set-aside designation. The product will be performed at the contractor's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the Defense Logistics Agency's Medical Supply Chain. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The prime IDV functions as a comprehensive global pharmaceutical support vehicle enabling the company to supply a vast range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The contract serves multiple federal customers including the Defense Health Agency and U.S. Coast Guard, demonstrating the contractor's capability to meet federal procurement requirements through open competition and deliver critical medical commodities across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 8/14/25 |